Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Short-course Radiotherapy (SCRT)”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353268
What this trial is testing

Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy.

Who this might be right for
Colorectal Cancer
Tao Zhang 76
Testing effectiveness (Phase 2)Looking for participantsNCT07284992
What this trial is testing

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC

Who this might be right for
Rectal CancerAdvanced Stage Colorectal CancerRadiotherapy
Shandong Provincial Hospital 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07837362
What this trial is testing

SCRT Combined With CAPOX and PD-1/CTLA4 Antibody for Early-stage Low Rectal Cancer

Who this might be right for
Early Low Rectal Cancer
Fudan University 34
Testing effectiveness (Phase 2)Looking for participantsNCT07347951
What this trial is testing

A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Wenzhou Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07646639
What this trial is testing

Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC

Who this might be right for
Rectal CancerRadiotherapy
The First Affiliated Hospital with Nanjing Medical University 122
Testing effectiveness (Phase 2)Looking for participantsNCT06802666
What this trial is testing

Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CancerNeoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 45
Testing effectiveness (Phase 2)Looking for participantsNCT07669220
What this trial is testing

A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)

Who this might be right for
Rectal AdenocarcinomaHigh-risk Locally AdvancedShort-course Radiotherapy (SCRT)+2 more
Sixth Affiliated Hospital, Sun Yat-sen University 76
Testing effectiveness (Phase 2)Looking for participantsNCT06787183
What this trial is testing

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Who this might be right for
Locally Advanced Rectal Cancer With Liver Metastases
Fujian Cancer Hospital 42
Testing effectiveness (Phase 2)Study completedNCT06333769
What this trial is testing

Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer

Who this might be right for
Mid-low Rectal Cancer
Fujian Cancer Hospital 38
Large-scale testing (Phase 3)Looking for participantsNCT07549399
What this trial is testing

SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

Who this might be right for
Rectal AdenocarcinomaHigh-Risk CancerMSS
Sixth Affiliated Hospital, Sun Yat-sen University 204
Testing effectiveness (Phase 2)Study completedNCT06908031
What this trial is testing

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaHigh-Risk CancerMSS
Sixth Affiliated Hospital, Sun Yat-sen University 49
Testing effectiveness (Phase 2)Looking for participantsNCT05576480
What this trial is testing

SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerLocally Advanced
Ruijin Hospital 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT06832917
What this trial is testing

Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)

Who this might be right for
Rectal Cancer
Wan He 238
Testing effectiveness (Phase 2)UnknownNCT05640726
What this trial is testing

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

Who this might be right for
Rectal Cancer
Fujian Cancer Hospital 30
Not applicableLooking for participantsNCT07474103
What this trial is testing

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Who this might be right for
Rectal Cancer, Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 49
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Testing effectiveness (Phase 2)Looking for participantsNCT06850103
What this trial is testing

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Who this might be right for
Colorectal CarcinomaOligometastasespMMR+2 more
First Affiliated Hospital of Zhejiang University 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07101666
What this trial is testing

Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer

Who this might be right for
Gastric Cancer
Washington University School of Medicine 20
Testing effectiveness (Phase 2)UnknownNCT05527821
What this trial is testing

Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Who this might be right for
Unresectable Advanced Solid TumorsBiliary Tract Tumors, Gastric Cancer, Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Looking for participantsNCT06864013
What this trial is testing

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Zhejiang University 116
Next Page